Exin Therapeutics, Inc.

CIK 2109179 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Exin Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Feb 10, 2026D0002109179-26-000001